Wu, S., & Shih, J. (2018). Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer. Mol Cancer.
Stile di citazione ChicagoWu, Shang-Gin, e Jin-Yuan Shih. "Management of Acquired Resistance to EGFR TKI–targeted Therapy in Advanced Non-small Cell Lung Cancer." Mol Cancer 2018.
Citazione MLAWu, Shang-Gin, e Jin-Yuan Shih. "Management of Acquired Resistance to EGFR TKI–targeted Therapy in Advanced Non-small Cell Lung Cancer." Mol Cancer 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.